Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Andersson, Per-Ola  [Clear All Filters]
2023
Lisak M, Nicklasson M, Palmason R, Wichert S, Isaksson C, Andersson P-O, Johansson J-E, Lenhoff S, Brune M, Hansson M. Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin. Sci Rep. 2023;13(1):22777.
2022
Vaht K, Brenner J, Ednersson SBram, Ljungman P, Brune M, Andersson P-O. Bone marrow expression of CD68/CD163 macrophages, IL-17, and FOXP3 cells in aplastic anaemia and their relation to prognosis. Eur J Haematol. 2022.
Harrysson S, Eloranta S, Ekberg S, Enblad G, El-Galaly TC, Sander B, Sonnevi K, Andersson P-O, Jerkeman M, Smedby KE. Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients. Br J Haematol. 2022.
2021
Veskovski L, Andersson P-O, Turesson I, Malmodin D, Pedersen A, Mellqvist U-H. Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High-dose Melphalan and Autologous Stem Cell Transplantation. Exp Hematol. 2021.
2019
Vaht K, Göransson M, Carlson K, Isaksson C, Lenhoff S, Sandstedt A, Uggla B, Winiarski J, Ljungman P, Andersson P-O, et al. High graft-versus-host disease-free, relapse/rejection-free survival and similar outcome of related and unrelated allogeneic stem cell transplantation for aplastic anemia - a nationwide Swedish cohort study. Biol Blood Marrow Transplant. 2019.